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Available online 9 November 2016Pre-transplantmyeloablation is associatedwithmarrowadipogenesis, resulting indelayed engraftment of hema-
topoietic stem cells (HSCs). This is strongly undesirable, especially when the donor HSCs are fewer in numbers or
have compromised functionality. The molecular mechanisms behind irradiation-induced marrow adipogenesis
have not been extensively investigated. Here we show that bone marrow (BM) cells, especially T-cells and stro-
mal cells, express and secrete copious amounts of BMP4 in response to irradiation, which causes the bone mar-
row stromal cells to commit to adipocyte lineage, thereby contributing to an increase in bone marrow
adipogenesis. We further demonstrate that Simvastatin inhibits the BMP4-mediated adipogenic commitment
of marrow stromal cells by inhibiting Ppar-γ expression. Importantly, Simvastatin does not prevent BMP4 secre-
tion by the BM cells, and thus does not interfere with its salutary role in post-transplant hematopoietic regener-
ation. Our data identify previously unknownmechanisms operative inmarrow adipogenesis post-myeloablation.
They also reveal themolecularmechanisms behind the advantage of using Simvastatin as a niche-targeting agent
to improve HSC engraftment.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Clinical and experimental observationsmade over the years have re-
vealed that pre-transplant myeloablation is associated with an increase
in marrow adipogenesis, which has a negative impact on post-trans-
plant hematopoietic repopulation (Snyder, 1965; Naveiras et al.,
2009). However, the cause of such post-myelosuppression bone mar-
row (BM) adipogenesis has been poorly investigated. BMP4 appears to
be an essential cytokine secreted in the BM microenvironment, since
abrogation of its secretion post-myelosuppression impairs hematopoi-
etic recovery (Goldman et al., 2009). In addition to its important role
in hematopoietic regeneration post-transplant, BMP4 is also known to
commit embryonic ﬁbroblasts (C3H10T1/2) to the adipocyte lineage
(Tang et al., 2004; Bowers et al., 2006; Suenaga et al., 2013), but wheth-
er it has a similar adipogenic effect on bonemarrow-derivedmesenchy-
mal stromal cells (BMSC) is not known. Similarly, whether BMP4 has
any role in post-myelosuppression marrow adipogenesis has not been
investigated. Given the important role played by BMP4 in post-trans-
plant hematopoietic recovery and its adipogenic capabilities, we hy-
pothesized that there could be an increase in secretion of BMP4 in the
BM microenvironment post-myelosuppression to facilitate hematopoi-
etic recovery, which would, however, also cause BMSCs to commit to
adipocyte lineage. We propose that this contributes to increasedgmail.com (V.P. Kale).
. This is an open access article underadipocyte formation post-myelosuppression. We report here the ﬁnd-
ings from our studies carried out to test this hypothesis.
2. Material and methods
2.1. Animal experiments
C57BL/6J mice purchased from Jackson Laboratory (Bar Harbor, ME,
USA), were housed and bred in the institutional experimental animal
facility. 8–12 week-old mice were used in the experiments. All animal
experimental procedures followed in the studywere approved by insti-
tutional animal ethics committee (IAEC).
Mice were subjected to total body lethal irradiation (9.5 Gy γ irradi-
ation, Co60 split doses given 4 h apart). Rate of irradiation used was
1.92 Gy per minute. In one set, bones were harvested 48 h post-irradia-
tion and ﬁxed in formalin for detection of BMP4 by immunohistochem-
istry (IHC) or BM cells were harvested for real time quantitative PCR
(RT-qPCR) experiments. In the second set, BM cellswere isolated imme-
diately after irradiation and cultured for 48 h for collection of condi-
tioned medium (CM). In the third set, BM ﬂuid was collected from the
bone of mice 48 h after irradiation. Bones, BM cells and BM ﬂuid from
non-irradiated mice were used as controls.
To study the effect of Simvastatin treatment on BMP4 secretion in
vivo, mice were daily fed with Simvastatin (25 mg/kg body weight,
Sigma-Aldrich, St. Louis, MO, USA) for one week prior to total body le-
thal irradiation and also at 24 h post- irradiation. 48 h post-irradiation,
bones were collected for detection of BMP4 by IHC and BM cells werethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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constitution and activation of Simvastatin has been described in details
in our previous publication (Bajaj et al., 2015).
2.1.1. Collection of conditioned medium
To demonstrate that marrow cells secrete BMP4 in response to irra-
diation, mice were sacriﬁced immediately after lethal irradiation (Co60
9.5 Gy) and both pairs of femur and tibia were collected. Bones were
chopped ﬁnely in the medium to collect BM cells. Cell suspension was
passed through 40 μM cell strainer (BD Bioscience, San Diego, CA,
USA). Cells were seeded in 10 ml of IMDM supplemented with 2% FBS
and the CM was collected after 48 h of incubation. CM of marrow cells
collected from non-irradiated mice was kept as control. The collection
volumes used for preparing CM in test set and control setwere precisely
matched. CM was centrifuged at 2000g for 5 min to remove cells and
further centrifuged at 12,000g for 30 min at 4 °C to remove cellular de-
bris. Onemilliliter of this CMwasused as commitmentmedium to study
secretion of adipogenic factors by BM cells in response to irradiation
(Online Supplementary Fig. S1A).
In another set of experiments, micewere sacriﬁced after 48 h of irra-
diation. Both pairs of femur and tibia were collected and chopped ﬁnely
in 10 ml of plain IMDM to collect BM ﬂuid. Clariﬁed CM and BM ﬂuid
were supplemented with PMSF and protease inhibitor cocktail (PIC,
Sigma) to avoid proteolysis and were vacuum concentrated. Total pro-
teins were precipitated using chilled acetone and the entire precipitate
was subjected to western blot analyses. The blots were probed with
anti-BMP4 antibody (Supplementary Table S1) (Abcam, Cambridge,
MA, USA).
2.1.2. BM immunohistochemistry
Femurs were ﬁxed in 4% paraformaldehyde, decalciﬁed and embed-
ded in parafﬁn. Sections of 4 μm thickness were cut. For immuno-detec-
tion of BMP4, the parafﬁn sectionswere antigen-retrieved using sodium
citrate buffer (10 mM, pH 6) in a pressure cooker. Endogenous peroxi-
dase was blocked using 3% H2O2 in 1× PBS and the sections were
blockedwith 2% BSA-PBS and 2%NormalHorse serum (Vector Laborato-
ries, Burlingame, CA, USA). The sectionswere incubatedwith anti-BMP4
(1:50, Abcam) primary antibody overnight at 4 °C, followed by incuba-
tion with biotinylated anti-rabbit secondary antibody (BD Bioscience)
and streptavidin horse radish peroxidase-conjugated tertiary antibody
(Vector Lab). Sections processed with isotype control were used as con-
trols. Staining was developed with DAB substrate (Invitrogen, Carlsbad,
CA, USA) and the slides were counterstained with hematoxylin.
2.1.3. Isolation of BMSCs
For isolation of primary bone marrow mesenchymal stromal cells
(BMSCs), both pairs of femur and tibia were collected and ﬂushed
with IMDM using 21G needle syringe to collect BM cells. Isolated cells
were cultured in IMDM supplemented with 20% FBS (mesenchymal
stem cell-qualiﬁed, STEMCELL Technologies, Vancouver, BC, Canada).
After 72 h, non-adherent cells were removed and adherent cells were
cultured for 15 days. Cells in the third passage were used to study
BMP4-mediated adipogenic commitment.
2.1.4. In vitro adipogenic differentiation assay:
Both, primary BMSCs andM2-10B4 (ATCC®CRL-1972™) (American
Type Culture Collection, Manassas, VA, USA), a murine bone marrow-
derived mesenchymal stromal cell line, were used to study adipogenic
potential of BMP4. Cellswere seeded in such amanner that they became
conﬂuent in 72 h. Post-conﬂuence, they were maintained for further
48 h. This period (72+48 h) is deﬁned as “commitment phase”. During
this period the cells were treated either with CM, BM ﬂuid or recombi-
nant BMP4 (25 ng/ml, Sigma), with orwithout the addition of inhibitors
(Experimental scheme is described in Online Supplementary Fig. S1A).
A set of cellswas lysed at this stage, either for protein ormRNAanalyses.
In parallel sets, the cells were treated with standard adipogenicdifferentiation medium containing Dexamethasone (1 μM), IBMX
(0.5 mM), Indomethacin (0.2 mM) (Sigma) and Insulin (10 μg/ml)
(Invitrogen) for 48 h. Thereafter, the cells were fed with insulin (2 μg/
ml) after every 72 h for 7–9 days. After formation of mature adipocytes,
cells were ﬁxed and stained with Oil Red O stain. The Oil Red O positive
adipocytes were counted under an inverted microscope (Tang et al.,
2004; Bajaj et al., 2011).
To assess the effect of various pharmacological compounds on
BMP4-mediated adipogenic commitment, the cells were treated with
either Noggin (100 ng/ml), T0070907 (0.75 μM, Sigma), LY294002
(10 μM), SB203580 (10 μM, Calbiochem) or Simvastatin (1.0 μM)during
the commitment phase.
2.1.5. Western blot analysis:
Protein concentration of cell lysates was assessed using micro BCA
protein assay kit (Pierce, Thermo scientiﬁc; Asheville, NC, USA). Equal
protein aliquots of cell lysates or total protein precipitates of concentrat-
ed CM/BM ﬂuid samples were separated on an SDS-PAGE gel and then
electrophoretically transferred to PVDF membrane (Bio-Rad, Berkeley,
California). The membranes were incubated for 1 h in blocking buffer
(5% BSA in TBST) [50 mM Tris, 150 mM NaCl, 0.1% Tween 20] and
then probed with the respective primary antibodies overnight at 4 °C
[PPARγ (1:1000; Cell Signaling Technology; Danvers, MA, USA), β-
Actin (1:5000, Sigma), BMP4 (1:1000, Abcam)]. Blots were washed
with TBST and incubated with an appropriate HRP- conjugated second-
ary antibody (Cell Signaling Technology). Immuno-reactive conjugates
were detected using LumiGlow substrate (Cell Signaling Technology)
according to the manufacturer's instructions. Densitometry was per-
formed using Image J software (NIH) and the values were normalized
with the input (β-actin).
2.1.6. Flow cytometry:
Doublets were excluded by FSC-H X FSC-W and SSC-H X SSC-W. Sin-
gle antibody-stained channels were used for compensation. Appropri-
ate isotype control antibodies were used for each antibody. All ﬂow-
qualiﬁed antibodies were purchased from (BD Biosciences; San Jose,
CA, USA), or eBioscience (San Diego, CA, USA). Speciﬁc clones of various
antibodies used are listed in Supplementary Table S1.
2.1.7. Sorting of various BM cell populations:
BM cells were harvested from non-irradiated and irradiated mice
(48 h post-irradiation) as described before. RBCs were lysed with RBC
lysis buffer and the cell suspensionwas passed through 40 μ cell strainer
(BD). Cells were stainedwith a cocktail of antibodies to analyze and sort
different BM cell populations [CD45-PE/Cy7, TER-119-PE (Erythrocytes
and erythroid lineage cells), CD45R (B220)-APC (B cells), CD3e PerCP-
Cyanine5.5 (T cells), CD11b and Ly-6G/Ly-6C- FITC (Myeloid cells),
CD41 APC-eFluor® 780 (Megakaryocytes)]. Gating strategy applied for
identiﬁcation and sorting of different cell population is depicted in On-
line Supplementary ﬁg. S2. Cells were sorted on ARIA III (SORP) ﬂow
cytometer (BD Bioscience). Sort-puriﬁed cells werewashedwith chilled
PBS and lysedusing lysis bindingbuffer (Invitrogen) formRNA isolation.
2.1.8. Gene expression analysis
Cellswere lysed in lysis/binding buffer andmRNAwas isolated using
the Dynabeads® mRNA DIRECT™ Puriﬁcation Kit (Invitrogen) accord-
ing tomanufacturer's instructions. The isolatedmRNAwas reverse tran-
scribed using Superscript III RT enzyme (Invitrogen). Samples without
reverse transcriptase were used to detect genomic DNA contamination.
Primers were designed using Primer-3 software V0.4.0. (http://prodo.
wi.mit.edu/primer3/). Primer sequences are listed in Table S2. Quantita-
tive PCRs were performed using the Platinum® SYBR® Green qPCR
SuperMix-UDG (Invitrogen) and analyzed on ABI 7500 fast system (Ap-
plied Biosystems, Foster City, CA, USA). Gene expression was normal-
ized with Gapdh. Relative gene expression was calculated as 2ddCt.
Non-irradiated cells were used as the calibrator. Efﬁciency of PCR
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(Mygind et al., 2002).
2.1.9. Statistics
Statistical analysis was performed using one-way repeated mea-
sures analysis of variance (One-Way RMANOVA) using Sigma Stat soft-
ware (Systat Software, Inc.). p b 0.05 was considered statistically
signiﬁcant. Results are expressed as mean value ± SEM of at least
three biological replicates.
3. Results
3.1. Bone marrow cells secrete adipogenic factor(s) in response to
irradiation
The marrow adipogenesis caused by myeloablation suggests that
perhaps the marrow milieu gets enriched with adipogenic factors
post-irradiation. We, therefore, examined whether the bone marrow
cells secrete adipogenic factors in response to irradiation. (Online
Supplementary Fig. S1A shows the experimental design). As seen in
Fig. 1A, the CM collected from BM cells of irradiated mice showedFig. 1.Marrow tissue responds to irradiation by secretion of BMP4. (A) CM of bonemarrow cell
well plate, and they were treated for 5 days with conditioned medium (CM) prepared from 48
then subjected to adipogenic differentiation using standard adipogenic inductionmedia. Numbe
CMprepared from48h culture ofmarrow cells (left panel) and BMﬂuid (right panel) collected f
dimeric conformation of themature BMP4 peptide was detected. Lower panel depicts densitom
shows representative bone sections fromnon-irradiated and irradiatedmice at 48 h post-irradia
(upper panel). As expected, the irradiated bones showed severe loss of cellularity after 48 h. Itm
selected for imaging. Arrows indicate BMP4 signal. Red arrows indicate BMcells, yellow arrows
represents 0.1 μm. (n=3, repeated 3 times). (D) Bmp4-speciﬁcmRNAwasmeasured by RT-qPC
irradiation. BM cells collected from non-irradiated mice were used as controls. n = 3. The dataadipogenic activity on the M2-10B4 stromal cells, revealing that lethal
irradiation leads to secretion of adipogenic factors by the survivingmar-
row cells.3.2. Conditioned medium of marrow cells and BM ﬂuid collected from irra-
diated mice have higher levels of BMP4
BMP4 has been shown to commit embryonic ﬁbroblasts to the adi-
pocyte lineage (Tang et al., 2004; Bowers et al., 2006; Suenaga et al.,
2013). Therefore, we examined whether the CM of marrow cells and
the BM ﬂuid collected from the bones of irradiatedmice show increased
levels of BMP4. The CM collected from BM cells and BM ﬂuid of irradiat-
ed mice vis-à-vis non-irradiated mice were subjected to western blot
analysis using anti-BMP4 antibody. A signiﬁcantly higher amount of
BMP4 was present in the CM of BM cells (Fig. 1B, left panel) and BM
ﬂuid collected from irradiated mice (Fig. 1B, right panel), as compared
to their respective non-irradiated controls.
IHC experiments were then performed on the sections of bones har-
vested 48 h post-irradiation. We observed that most of the surviving
marrow cells of irradiated mice showed an increased expression ofs collected from irradiatedmice has adipogenic activity. M2-10B4 cells were seeded in 24-
h culture of marrow cells collected from irradiated or non-irradiated mice. The cells were
r of Oil RedO positive adipocytes formedperwell was scored. (B)Western blot analyses of
rom thebones of non-irradiated and irradiatedmice. A single bandof 36kDa representing a
etric analyses of the bands. A.U.= Arbitrary Units. N= 3, ***p b 0.001, **p 0.002. (C) Panel
tion, immuno-stainedwith anti-BMP4 antibody (lower panel) orwith an isotype antibody
ay be noted that for comparative purposes, the areas showing comparable cellularity were
indicate cells lining bone structures and green arrows indicate cells lining blood vessels. Bar
R in un-fractionated BMcells collected from irradiatedmice at 48 h, day 5 and day 10 post-
are represented as Mean ± SEM. ***p b 0.001. Experiments were repeated three times.
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row of non-irradiated controls (Fig. 1C).
These observations, considered together with the adipogenic activi-
ty shown by the CMofmarrow cells collected from irradiatedmice, sug-
gest that marrow cells secrete BMP4 in response to irradiation and that
this secreted BMP4 perhaps causes adipogenic differentiation of BMSCs.
3.3. Irradiation provokes the secretion of BMP4 by marrow cells
To assess whether irradiation leads to increased expression and se-
cretion of BMP4 by marrow cells, we performed RT-qPCR analyses of
themarrowmononuclear cells isolated frommice 48 h post-irradiation.
The data showed that the cells collected from the marrow of irradiated
mice expressedmuch higher levels of Bmp4-speciﬁc mRNA (N90 folds),Fig. 2. T cells and stromal cells are themajor contributors in BMP4 secretion post-irradiation. (A
irradiated mice, as compared to their non-irradiated counterparts. (B) Percentage of various ce
Contribution of various cells types in BMP4 secretion, under non-irradiated (left panel) and irra
cells present in themarrowpre- and post-irradiation (48 h) as determined by Trypan Blue dye e
n = 3. The data are represented as Mean ± SEM. *** p b 0.001. Experiments were repeated thas compared to those isolated from the marrow of non-irradiated mice
(Fig. 1D). We tracked Bmp4 expression in BM cells at day 5 and day 10
post-transplant and found that the expression of Bmp4 increased signif-
icantly at day 5. However, at day 10 post-irradiation, the expression
levels returned to those seen in control cells, indicating that the process
is ﬁnely regulated (Fig. 1D).
3.4. Identiﬁcation of the cell type contributing to BMP4 secretion in themar-
row microenvironment:
To identify the cell type responsible for higher BMP4 secretion in re-
sponse to irradiation, we sort-puriﬁed various phenotypically-deﬁned
BMcell sub-populations viz. B cells, T cells,myeloid cells,megakaryocytes,
stromal cells and erythroid cells from themarrowof both, non-irradiated) Fold difference in Bmp4 expression in various cell types sort-puriﬁed from themarrow of
ll types in the marrow of non-irradiated (left panel) and irradiated (right panel) mice. (C)
diated (right panel) conditions. Also refer to Table 1 and its legend. (D) Number of viable
xclusion test is graphically illustrated. Representative data of one experiment are depicted.
ree times.
650 M.S. Bajaj et al. / Stem Cell Research 17 (2016) 646–653and irradiated mice (48 h post-irradiation) (Online Supplementary Fig.
S2) and subjected them independently to RT-qPCR analyses to quantify
Bmp4-mRNA expression. We found that most cell types, except B cells,
showed an increase in Bmp4 expression in response to irradiation, as
compared to their non-irradiated counterparts (Fig. 2A, Table 1). Impor-
tantly, stromal cells and T cells sorted from the marrow of irradiated
mice showed 139-folds and 111-folds increase in the Bmp4 expression
respectively. Since these sub-populations are present at varying percent-
ages in the marrow microenvironment, the observed fold increase in
Bmp4 expression values shown by the sort-puriﬁed cells may not reﬂect
their actual contribution to the total Bmp4 expressed by all the BM cells
collectively. Therefore, we computed their relative contribution to Bmp4
expression in the BM by normalizing the levels of Bmp4 expression in
each sub-population with their respective frequency in the un-fraction-
ated BM cells, pre- and post-irradiation (Fig. 2B, Refer to Table 1 and its
legend for details). These analyses revealed that under non-irradiated
conditions, B cells contributed maximally to Bmp4 expression (59.88%),
followed by stromal cells (19.35%) and T cells (14.39%), whereas under
irradiated conditions, T cells contributed maximally (55.46%), followed
by stromal cells (43.11%; Fig. 2C). Post-irradiation, the contribution by
B cells went down drastically from 59.88% to 0.14% (Fig. 2C). Although
the sum of the Bmp4-expression shown by individual sub-populations
sort-puriﬁed from irradiated BM cells showed 156-folds higher Bmp4
expression, as compared to the sum of the Bmp4-expression shown by
individual sub-populations sort-puriﬁed from non-irradiated BM cells
(Table 1), the total surviving BM cells in irradiated marrow were
only10% of the non-irradiated marrow (Fig. 2D). Therefore, the effective
increase in irradiation-induced Bmp4 expression in situ would be 15.6-
folds higher, as compared to the non-irradiated marrow (Table 1),
which is sufﬁcient to induce adipogenic commitment of BMSCs.
Collectively, these data clearly establish thatmarrow tissue responds
to irradiation with de novo expression and secretion of BMP4, and T
cells and stromal cells are the main contributors to BMP4 secretion.
3.5. BMP4 commits BMSCs to adipocyte lineage:
To determine whether BMP4 induces adipogenic commitment of
stromal cells, M2-10B4 cells were treated with recombinant BMP4 for
5 days, i.e. during the commitment phase. The treated cells were then
fed with standard adipogenic differentiation medium for 48 h, with or
without the addition of BMP4. Feeding with insulin was continued for
7–10 days and the number of Oil Red O positive adipocytes was scored
(Online Supplementary Fig. S1A).
We found that a large number of adipocytes formed in the culture
when BMP4was present during the commitment phase (Fig. 3A, fourthTable 1
Determination of relative contribution in Bmp4 expression by various cell types:
We computed the irradiation-induced fold change in Bmp4 expression in each sub-population b
non-irradiated mice. Total BMP4 expression (arbitrary units) by individual sub-population was
sion). Total BMP4 expression (arbitrary units) was obtained by summing up these values. From
in marrow was calculated.
BM
sub-population
Non-irradiated Irra
Fold increase in BMP4
expression as compared
to total BM cells
(non-Irradiated)
%
population
in total bone
marrow
cells
Total
BMP4
secreted
(A.U)*
%
contribution
in total
BMP4
expression
Fold
exp
to t
(no
B Cells 12.54 24.39 3.06 59.88 9.00
T cells 9.00 8.16 0.73 14.39 100
Myeloid Cells 0.08 38.39 0.03 0.64 1.41
Stromal Cells 29.51 3.35 0.99 19.35 410
Megakaryocytes 2.04 2.87 0.06 1.15 105
Erythroid Cells 1.06 22.10 0.23 4.60 4.60
Total BMP4 expression 5.11 Tota
Since BM cellularity after irradiation is 10% of total BM cells in non-irradiated condition, eff
higher as compared to BM cells of non-irradiated mice.
Signiﬁcant changes in Bmp4 expression are highlighted by a bold font. * A.U. - Arbitrary Units.bar; Online Supplementary Fig. S1B), while its absence during this peri-
od (either in the ﬁrst 72 h or in the next 48 h) reduced the number of
adipocytes signiﬁcantly (Fig. 3A, second and third bar). Presence of
BMP4 in the differentiation phasewas not necessary for the progression
of adipogenesis, indicating that the process was irreversible (Fig. 3A,
fourth bar). However, if BMP4was added in the differentiationmedium,
the number of adipocytes increased further (Fig. 3A, last bar). Incorpo-
ration of Noggin, which prevents the interaction of BMP4with its recep-
tors, in the medium abrogated the BMP4-mediated adipogenic
commitment (Fig. 3B), establishing the speciﬁcity of the observed
phenomenon.
A small molecule inhibitor screen applied for major signaling path-
ways regulating adipogenesis revealed that the BMP4-mediated
adipogenic commitment involved PPAR-γ and PI3K signaling pathways
(Fig. 3C). Surprisingly, inhibition of p38 kinase signiﬁcantly increased
the number of adipocytes, suggesting that p38 acts as a negative regula-
tor of the process in these cells (Fig. 3C, last bar).
Collectively, these data clearly reveal that BMP4 commits the BMSCs
to the adipocyte lineage, and that this can be prevented by PPAR-γ and
PI3K inhibitors.3.6. Simvastatin inhibits BMP4-mediated adipogenic commitment of BMSCs
We have previously reported that Simvastatin inhibits post-irradia-
tion marrow adipogenesis in vivo (Bajaj et al., 2015). Here, we further
determined whether Simvastatin could inhibit BMP4-mediated
adipogenic commitment of the bone marrow stromal cells. Both, M2-
10B4 cells and primary BMSCs were treated with BMP4 in the presence
or absence of Simvastatin during the commitment phase, followed by
the standard adipogenic differentiation protocol. Quantiﬁcation of Oil
Red O positive adipocytes showed that Simvastatin suppressed BMP4-
mediated adipocyte formation in M2-10B4 cells as well as in primary
BMSCs (Fig. 3D-E). Simvastatin could not completely inhibit the
BMP4-mediated adipogenesis in M2-10B4 cells. The results of RT-
qPCR experiments done with these cells (Fig. 3F) further revealed that
Simvastatin inhibited the BMP4-mediated up-regulation of Ppar-γ, a
key transcription factor involved in adipogenesis. Western blot experi-
ments performed onM2-10B4 cells also showed that Simvastatin signif-
icantly inhibited the BMP4-induced up-regulation of PPAR-γ (Fig. 3G).
Simvastatin did not affect the BMP4-mediated activation of SMAD1/5/
8, AKT or ERK signaling pathways (data not shown).
Collectively, these data show that Simvastatin inhibits BMP4-
mediated adipogenic commitment of stromal cells by suppressing
PPAR-γ.y normalizing the data with the level of Bmp4 expression in un-fractionated BM cells from
measured using a formula: (% population divided by 100× fold increase in Bmp4 expres-
this total Bmp4 expression, % contribution by each sub-population in total BMP4 secretion
diated Fold increase in
BMP4 expression
over non-irradiated
counterpart
increase in BMP4
ression as compared
otal BM cells
n-Irradiated)
%
population
in total bone
marrow
cells
Total
BMP4
secreted
(A.U)*
%
contribution
in total
BMP4
expression
12.22 1.10 0.14 0.72
5.49 44.08 443.22 55.46 111.67
4.07 0.06 0.01 16.65
2.22 8.40 344.59 43.11 139.03
.07 9.15 9.61 1.20 51.52
14.14 0.65 0.08 4.32
l BMP4 expression 799.23 156.49
ective Bmp4 expression in BM of irradiated mice is 15.64-folds 15.64
Fig. 3. BMP4 irreversibly commits marrow stromal cells to adipogenic fate. (A) Effect of addition of BMP4 at various time points on adipocyte formation in M2-10B4 stromal cells is
depicted. (B) Inhibitory effect of Noggin (100 ng/ml) addition on BMP4-mediated adipogenesis shows that the effect is mediated by BMP4-BMPr1A interactions. (C) Effect of inhibitors
of PPAR-γ (T0070907, 0.75 μM), PI3K (LY294002, 10 μM) and p38 (SB203580, 10 μM) signaling pathways on BMP4-mediated adipogenesis. Inhibitory effect of Simvastatin (1 μM) on
BMP4-mediated adipogenic differentiation of M2-10B4 cells (D) and primary BMSCs (E) is graphically illustrated. (F) RT-q-PCR experiments were done to analyze Ppar-γ expression in
M2-10B4 cells and primary BMSCs treated with BMP4 in the presence or absence of Simvastatin (1 μM). (G) Western blot analysis of M2-10B4 cells treated with BMP4 in the presence
or absence of Simvastatin (1 μM) for detection of PPAR-γ. Right panel shows Densitometric analysis of the bands (N = 3). The data were normalized with β-actin. A.U. = Arbitrary
Units. ***p b 0.001, **p 0.002. Experiments were repeated three times.
651M.S. Bajaj et al. / Stem Cell Research 17 (2016) 646–6533.7. Simvastatin does not interferewith irradiation-induced BMP4 secretion
Since BMP4 is critical for hematopoietic recovery post-
myelosuppression (Goldman et al., 2009), it is vital that Simvastatin
treatment does not interfere with the secretion of this important cyto-
kine. To conﬁrm this, mice were treated with Simvastatin (25 mg/kg
body weight) for 7 days before irradiation followed by one treatment24 h post-irradiation. Results of RT-qPCR experiments performed with
BM cells collected 48 h post-irradiation from control-irradiated and
Simvastatin-treated-irradiated mice showed comparable expression of
Bmp4-speciﬁc mRNA (Fig. 4A). IHC experiments performed on bone
sections of irradiated un-treated and irradiated Simvastatin-treated
mice also showed similar levels of BMP4 in both sets (Fig. 4B). These
data demonstrate that Simvastatin does not interfere with the
Fig. 4. Simvastatin does not interfere with BMP4 secretion by marrow cells (A) Quantiﬁcation of Bmp-4-speciﬁc mRNA expression in BM cells harvested from control-irradiated and
Simvastatin-treated irradiated mice. N = 3. Data are represented as mean ± SEM. NS = not signiﬁcant. (B) Panel shows representative bone sections of control-irradiated and
Simvastatin-treated irradiated mice 48 h post-irradiation, immuno-stained with anti-BMP4 antibody (lower panel) or with an isotype antibody (upper panel) are depicted. Arrows
indicate BMP4 signal in various BM cells. Bar represents 0.1 μm. n = 3. The data are represented as Mean ± SEM. NS-non-signiﬁcant. Experiments were repeated three times.
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adipogenic activity on marrow stromal cells.
4. Discussion
Pre-transplant myeloablation has been consistently seen to be asso-
ciatedwith an increase in the number of adipocytes in the bonemarrow
(Snyder, 1965; Naveiras et al., 2009; Cao et al., 2011). Thesemarrow ad-
ipocytes were considered as passive space ﬁllers till Naveiras et al. dem-
onstrated that irradiation-induced bone marrow adipocytes actively
suppress hematopoiesis and that pharmacological inhibition of adipo-
genesis with a PPAR-γ antagonist resulted in an increase in donor cell
engraftment (Naveiras et al., 2009). However, the molecular mecha-
nisms behind irradiation-induced marrow adipogenesis have not been
extensively investigated. Herewe have identiﬁed a previously unknown
mechanism behind irradiation-inducedmarrow adipogenesis. Our ﬁnd-
ings reveal that BMP4 is secreted by the bone marrow cells in response
to irradiation, which then commits the BMSCs to the adipocyte lineage,
contributing to an increase in adipocyte formation. While the role of
BMP4 in inducing osteogenesis and bone formation in bone marrow
stromal cells has been reported (Rahman et al., 2015); its potential to
have an adipogenic effect on BMSCs was not known. We for the ﬁrst
time report here the adipogenic effect of BMP4 on BMSCs.
Although irradiation-induced secretion of various interleukins and
inﬂammatory cytokines has been reported (Bigildeev et al., 2013;
Fukumoto et al., 2013), we focused our studies on BMP4 for two impor-
tant reasons; (i) its secretion in the BM niche is crucial for hematopoiet-
ic recovery (Goldman et al., 2009); (ii) it is known to have an adipogenic
effect on the embryonic ﬁbroblasts (Tang et al., 2004; Bowers et al.,
2006) and is also critically required for the onset of adipogeneic differ-
entiation (Suenaga et al., 2013).
Osteoblasts, endothelial cells andmegakaryocytes present in the BM
microenvironment have been shown to express BMP4 (Goldman et al.,
2009). Consistent with this, we found that stromal cells express maxi-
mum amount of Bmp4-speciﬁc mRNA as compared to any other cell
type under steady-state condition and its levels increase signiﬁcantly
in response to irradiation. However, under steady state conditions stro-
mal cells are fewer in numbers in themarrowmicroenvironment (~3%),
and therefore, their effective contribution to total BMP4 expression be-
comes less (19.35%). On the other hand, under irradiated conditions
both, the relative % of stromal cells as well as the Bmp4 expressed by
them increase, and therefore, post-irradiation their relative contribution
to the total BMP4 secretion increases signiﬁcantly (43.11%).T cells are known to be relatively radio-resistant, as compared to
other marrow cells (Bosco et al., 2010). Consistent with this report, we
found that the T cells form a signiﬁcant percentage of the surviving pop-
ulation of marrow cells after 48 h of irradiation, as compared to that
under steady state conditions (44.08% vs. 8.16% respectively). T cells iso-
lated from themarrowof irradiatedmice showed a strikingly higher ex-
pression of Bmp4, as compared to non-irradiated counterparts. This
irradiation-induced increase in Bmp4 expression, coupled with their
radio-resistance, makes T-cells the major contributors of BMP4 secre-
tion in the marrow microenvironment after irradiation. Under steady
state conditions, B cells contribute maximally to total BMP4 expression
in the marrow, but under irradiated conditions their contribution is
negligible.
Collectively, our data showed that under irradiated conditions, T
cells and stromal cells are the major contributors in BMP4 secretion in
the marrow microenvironment. Even though the total viable cell num-
ber in irradiated marrow is almost 10-folds less than in non-irradiated
marrow, these surviving cells express signiﬁcantly higher amounts of
BMP4, which can mediate bone marrow adipogenesis. This is the ﬁrst
report showing the role of B cells and T cells in BMP4 secretion in the
marrow microenvironment, under steady state and post-irradiation
conditions, respectively.
Adipogenesis in the marrow is associated with bone marrow failure
and occurs during bonemarrow transplants 2–4weeks after irradiation.
Here we have shown that BMP4 levels in themarrow rise steeply at day
5 post-irradiation and then return to normal. This could raise concerns
about it causing marrow adipogenesis. However, we have also shown
that BMP4 is important mainly during the commitment phase
(Fig. 3A) and its presence is not required during adipogenic differentia-
tion. These data suggest that similar “hit and run” phenomenon may
also be occurring in themarrow compartment duringmyelosuppression.
Since BMP4 secretion in the bone marrow microenvironment is es-
sential for hematopoietic recovery (Goldman et al., 2009), an inhibitor
of BMP4 signaling cannot be used to prevent irradiation-induced
BMP4-mediatedmarrow adipogenesis. Inhibition of PPAR-γ has already
been shown to prevent post-irradiation adipogenesis (Naveiras et al.,
2009). Therefore, use of a PPAR-γ inhibitor like Simvastatin, which
would not interferewith BMP4 signaling associatedwith its hematopoi-
etic supportive activity, would be a better approach to minimize adipo-
genesis. This is supported by our earlier observations that Simvastatin
prevents irradiation-induced marrow adipogenesis in vivo (Bajaj et al.,
2015). In the present study we demonstrate that irradiation-provoked
BMP4-mediated adipogenic commitment of BMSCs can also be
653M.S. Bajaj et al. / Stem Cell Research 17 (2016) 646–653prevented by Simvastatin. We further show that the molecular mecha-
nism underlying this effect involves suppression of BMP4-mediated ac-
tivation of Ppar-γ, a key transcription factor involved in adipogenesis.
This could be a mechanism for reduced post-irradiation adipogenesis
in Simvastatin-treated recipients shown previously (Bajaj et al., 2015).
It is worth noting that Simvastatin does not interfere with irradiation-
induced BMP4 secretion, thus leaving its supportive role in HSC engraft-
ment undisturbed. These data underscore the advantages of using Sim-
vastatin as a niche-targeting agent to combat post-transplant marrow
adipogenesis.
5. Conclusion
In conclusion,we show thatmarrow cells, especially T cells and stro-
mal cells, respond to irradiation by secreting copious amounts of BMP4
to support post-transplant regeneration of hematopoiesis, but BMP4
also has the ability to induce adipogenic commitment of BMSCs via in-
creased expression of Ppar-γ. Therefore, we propose that irradiation-
provoked secretion of BMP4 is one of the primary cause of marrow ad-
ipogenesis post-myelosuppression. Simvastatin inhibits BMP4-induced
Ppar-γ expression without affecting irradiation-provoked BMP4 secre-
tion. Therefore, it could potentially serve as a good niche-targeting
agent in clinical transplantations to minimize post-irradiation adipo-
genesis and increase the efﬁciency of HSC engraftment.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2016.11.015.
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